Amyris Inc

NASDAQ:AMRS   9:47:34 AM EDT
11.97
+0.68 (+6.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.86B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$69.44 Million
Adjusted EPS-$0.12
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

AMYRIS, INC. Stock, NASDAQ:AMRS

5885 HOLLIS STREET, SUITE 100, EMERYVILLE, CA 94608
United States of America
Phone: 510-450-0761
Number of Employees: 503

Description

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.